Nektar Regains Full Rights Of REZPEG From Eli Lilly, Plans To Initiate Phase 2b Study

(RTTNews) - Nektar Therapeutics (NKTR) Thursday announced that it will be regaining the full rights to REZPEG from Eli Lilly and Company. The comp...

Related Keywords

Eli Lilly ,Howardw Robin ,